Mountains and seas converge, and medical knowledge flows freely. To deepen medical exchanges and cooperation with South Pacific island nations, the “Fifth Island Nations Advanced Medical Talent Training Program,” organized by the Guangdong Provincial Health Commission, held its on-site exchange activity successfully on July 25. Fourteen senior healthcare professionals from seven island nations, Fiji, Papua New Guinea, Vanuatu, Samoa, Tonga, Solomon Islands, and Kiribati, visited the Foshan Fosun Chancheng International Medical Center (FIMC) for an on-site inspection and discussion session, gaining firsthand experience of Foshan's internationally oriented healthcare services and distinctive traditional Chinese medicine offerings.

On July 12, the National Academic Study Visit and Seminar on the Development of International Medical Departments at Grade III Level A Hospitals was successfully held at Foshan Fosun Chancheng Hospital under the theme "International Standards, Local Strengths and High-Quality Development."

In June 2026, China’s National Medical Products Administration approved the launch of Satricabtagene Autoleucel Injection, also known as Kailimei®. It is an autologous CAR-T cell therapy product targeting CLDN18.2.